Broadening the Debate About Post-trial Access to Medical Interventions: A Qualitative Study of Participant Experiences at the End of a Trial Investigating a Medical Device to Support Type 1 Diabetes Self-Management-Reference-Cited by-同舟云学术

Broadening the Debate About Post-trial Access to Medical Interventions: A Qualitative Study of Participant Experiences at the End of a Trial Investigating a Medical Device to Support Type 1 Diabetes Self-Management

Published:2019-04-03 Issue:2 Volume:10 Page:100-112
ISSN:2329-4515
Container-title:AJOB Empirical Bioethics
language:en
Short-container-title:AJOB Empirical Bioethics

Author:

Lawton J.¹^ORCID,Blackburn M.¹,Rankin D.¹,Werner C.¹^ORCID,Farrington C.²,Hovorka R.³⁴^ORCID,Hallowell N.⁵

Affiliation:

1. Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom;

2. Cambridge Centre for Health Services Research, University of Cambridge, United Kingdom;

3. Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom;

4. Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom;

5. Wellcome Centre for Ethics and Humanities and the Ethox Centre, Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, United Kingdom

Funder

Juvenile Diabetes Research Foundation International

Publisher

Informa UK Limited

Subject

Health Policy,Philosophy,Health(social science)

Link

https://tandfonline.com/doi/pdf/10.1080/23294515.2019.1592264

Reference38 articles.

1. Human dignity as a basis for providing post-trial access to healthcare for research participants: a South African perspective

2. ‘FAIR BENEFITS’ ACCOUNTS OF EXPLOITATION REQUIRE A NORMATIVE PRINCIPLE OF FAIRNESS: RESPONSE TO GBADEGESIN AND WENDLER, AND EMANUEL ET AL.

3. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol